More about the current move away from beta-blocker therapy for hypertension as discussed by speakers at the 2013 ASH annual meeting. Following are some more of the key points, including a discussion of so-called beta-blockers "plus."
Patients with resistant hypertension and hypertensive patients prone to hyperkalemia are on the rise. They are not easy to care for, but certain “tricks of the trade” can help. Details here.